Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host cell adhesion proteins, also known as Cell Adhesion Molecules (CAMs), are a diverse group of cell-surface glycoproteins that facilitate physical interactions between cells or between cells and the extracellular matrix (Source: Gumbiner, 1996). These proteins are categorized into several families, including integrins, selectins, cadherins, and the immunoglobulin superfamily, and they play fundamental roles in tissue morphogenesis, wound healing, and immune cell trafficking (Source: Janeway's Immunobiology). In the context of infectious diseases, many viruses and bacteria exploit these proteins as primary attachment factors or entry receptors to invade host tissues (Source: Smith et al., 2018). For instance, the CD4 molecule is a critical adhesion protein used by HIV-1, while various integrins are utilized by pathogens like adenovirus and Borrelia burgdorferi. Therapeutic agents targeting these proteins, such as monoclonal antibodies, aim to competitively inhibit these interactions to treat infections or chronic inflammatory conditions like multiple sclerosis and Crohn's disease (Source: PMID: 29155424). However, because host adhesion proteins are essential for normal physiological processes, their pharmacological blockade can lead to significant safety risks, most notably an increased susceptibility to opportunistic infections due to impaired immune surveillance (Source: FDA Tysabri Label).
Blockade of cell-surface protein interactions to inhibit pathogen entry or immune cell migration (Source: PMID: 30245010).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host cell adhesion protein (CAM).